Neuroderm Balance Sheet - Annual (NASDAQ:NDRM)

Add to My Stocks
$38.85 $0 (0%) NDRM stock closing price Oct 18, 2017 (Closing)

The financial analysis of a company like Neuroderm involves checking the three financial statements of the company in detail, of which the balance sheet is one. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Neuroderm stock analysis. Annual results are typically accompanied with the company releasing financial statements. Neuroderm balance sheet indicates an asset turnover ratio of and debt to equity ratio of . Also check Neuroderm revenue and Neuroderm operating cash flow for the same period.

View latest 10 year balance sheet data to check Neuroderm financial performance.
show more
Fiscal year is Jan - Dec20162015201420132012
Cash107.17M84.73M43.23M2.43M-
Marketable Securities45.05M15.1M---
Receivables-----
Inventory-----
Raw Materials-----
Work In Progress-----
Finished Goods-----
Notes Receivable-----
Other Current Assets2.66M----
Total Current Assets
154.9M100.46M43.74M2.97M-
Property Plant & Equipment1.31M----
Accumulated Depreciation-----
Net Property Plant & Equipment
-----
Investment & Advances-----
Other Non-Current Assets-----
Deferred Charges-----
Intangibles-----
Deposits & Other Assets-----
Total Assets
156.06M100.86M43.91M3.05M-
Notes Payable-----
Accounts Payable6.49M3.76M3.4M1.72M-
Current Portion Long-Term Debt-----
Current Portion Capital Leases-----
Accrued Expenses-----
Income Taxes Payable-----
Other Current Liabilities--1.03M--
Total Current Liabilities
6.49M3.81M4.44M1.72M-
Mortgages-----
Deferred Taxes/Income-----
Convertible Debt---3.24M-
Long-Term Debt-----
Non-Current Capital Leases-----
Other Long-Term Liabilities---1.72M-
Total Liabilities
6.49M3.81M4.44M6.69M-
Minority Interest-----
Preferred Stock-----
Common Stock Net-----
Capital Surplus320.33M239.29M167.28M100.06M-
Retained Earnings-180.73M-148.23M-132.62M-102.76M-
Treasury Stock-----
Other Liabilities9.91M5.96M4.79M-0.94M-
Shareholders Equity149.57M97.05M39.46M-3.64M-
Total Liabilities & Shareholders Equity156.06M100.86M43.91M3.05M-
All figures in USD. M: Millions of USD, B: Billions of USD.

The latest Neuroderm stock price, and Neuroderm historical stock prices show the stock price movement over time, and the Neuroderm PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: NDRM total assets, which was at $156.06M for 2016 is a balance sheet item representing value of what Neuroderm owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Neuroderm is $6.49M. Shareholders' equity comes under liabilities as it is money the company owes the holders of NDRM stock.

Neuroderm Balance Sheet - Key Ratios